drugset / Trial / NCT00286312
Myocardial Infarction Size Reduction With Atorvastatin
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if oral atorvastatin administered just before percutaneous coronary angioplasty for acute myocardial infarction improves early and late heart function as compared to placebo.
Timeline
- Start
- 2006-02
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | Oral |